Evolus, Inc. (EOLS)

USD 9.36

(-8.59%)

Total Assets Summary of Evolus, Inc.

  • Evolus, Inc.'s latest annual total assets in 2023 was 188.99 Million USD , up 6.19% from previous year.
  • Evolus, Inc.'s latest quarterly total assets in 2024 Q1 was 226.17 Million USD , up 19.67% from previous quarter.
  • Evolus, Inc. reported annual total assets of 177.98 Million USD in 2022, down -30.88% from previous year.
  • Evolus, Inc. reported annual total assets of 257.48 Million USD in 2021, up 23.16% from previous year.
  • Evolus, Inc. reported quarterly total assets of 233.77 Million USD for 2024 Q2, up 3.36% from previous quarter.
  • Evolus, Inc. reported quarterly total assets of 167.97 Million USD for 2023 Q3, down -0.6% from previous quarter.

Annual Total Assets Chart of Evolus, Inc. (2023 - 2015)

Historical Annual Total Assets of Evolus, Inc. (2023 - 2015)

Year Total Assets Total Assets Growth
2023 188.99 Million USD 6.19%
2022 177.98 Million USD -30.88%
2021 257.48 Million USD 23.16%
2020 209.06 Million USD -13.05%
2019 240.44 Million USD 39.92%
2018 171.84 Million USD 12.88%
2017 152.23 Million USD 96.44%
2016 77.49 Million USD -4.68%
2015 81.3 Million USD 0.0%

Peer Total Assets Comparison of Evolus, Inc.

Name Total Assets Total Assets Difference
Journey Medical Corporation 76.84 Million USD -145.934%
ANI Pharmaceuticals, Inc. 904.42 Million USD 79.103%
Aquestive Therapeutics, Inc. 57.41 Million USD -229.162%
Pacira BioSciences, Inc. 1.57 Billion USD 87.995%
Sunshine Biopharma, Inc. 27.34 Million USD -591.112%
Sunshine Biopharma, Inc. 27.34 Million USD -591.112%
SCYNEXIS, Inc. 128.41 Million USD -47.181%
Safety Shot Inc 12.7 Million USD -1387.098%
Alpha Teknova, Inc. 128.58 Million USD -46.981%
Collegium Pharmaceutical, Inc. 1.14 Billion USD 83.469%
Bright Green Corporation 17.4 Million USD -986.005%
Dynavax Technologies Corporation 997.09 Million USD 81.045%
Esperion Therapeutics, Inc. 205.79 Million USD 8.162%
Cosmos Health Inc. 66.29 Million USD -185.084%
PainReform Ltd. 9.93 Million USD -1803.303%
China SXT Pharmaceuticals, Inc. 23.12 Million USD -717.216%
Embecta Corp. 1.21 Billion USD 84.437%
Intra-Cellular Therapies, Inc. 728.29 Million USD 74.049%
Procaps Group, S.A. 460.18 Million USD 58.93%
Theratechnologies Inc. 77.76 Million USD -143.025%
Harrow Health, Inc. 311.75 Million USD 39.376%
Sonoma Pharmaceuticals, Inc. 14.89 Million USD -1169.039%
Biofrontera Inc. 27.93 Million USD -576.636%
DURECT Corporation 45.18 Million USD -318.239%
Supernus Pharmaceuticals, Inc. 1.4 Billion USD 86.586%
Cronos Group Inc. 1.13 Billion USD 83.337%
OptiNose, Inc. 107.72 Million USD -75.438%
Ironwood Pharmaceuticals, Inc. 471.07 Million USD 59.879%
Kala Pharmaceuticals, Inc. 55.94 Million USD -237.804%
RedHill Biopharma Ltd. 23.04 Million USD -720.05%
Organogenesis Holdings Inc. 460.02 Million USD 58.916%
Guardion Health Sciences, Inc. 11.91 Million USD -1485.796%
Cumberland Pharmaceuticals Inc. 81.77 Million USD -131.116%
Radius Health, Inc. 1.71 Billion USD 88.986%
Universe Pharmaceuticals INC 53.28 Million USD -254.679%
ProPhase Labs, Inc. 91.92 Million USD -105.596%
Phibro Animal Health Corporation 982.18 Million USD 80.757%
Procaps Group S.A. 460.18 Million USD 58.93%
Alvotech 950.09 Million USD 80.107%
TherapeuticsMD, Inc. 43.3 Million USD -336.394%
Viatris Inc. 47.68 Billion USD 99.604%
Rockwell Medical, Inc. 52.17 Million USD -262.253%
Aytu BioPharma, Inc. 118.09 Million USD -60.039%
SIGA Technologies, Inc. 254.83 Million USD 25.835%
Tilray Brands, Inc. 4.33 Billion USD 95.64%
Lifecore Biomedical, Inc. 273.7 Million USD 30.948%
Shineco, Inc. 84.17 Million USD -124.518%
PetIQ, Inc. 868.22 Million USD 78.232%
Regencell Bioscience Holdings Limited 8.43 Million USD -2139.788%
Incannex Healthcare Limited 17.04 Million USD -1008.688%
Neurocrine Biosciences, Inc. 3.25 Billion USD 94.187%
Alimera Sciences, Inc. 153.52 Million USD -23.106%
Silver Spike Investment Corp. 88.57 Million USD -113.373%
Assertio Holdings, Inc. 286.41 Million USD 34.013%
Shuttle Pharmaceuticals Holdings, Inc. 5.95 Million USD -3075.51%
Petros Pharmaceuticals, Inc. 33.79 Million USD -459.235%
Clever Leaves Holdings Inc. 31.24 Million USD -504.929%
Cyclo Therapeutics, Inc. 13.24 Million USD -1326.665%
Avadel Pharmaceuticals plc 261.12 Million USD 27.622%
Hempacco Co., Inc. 18.04 Million USD -947.482%
Talphera, Inc. 20.39 Million USD -826.688%
Alvotech 950.09 Million USD 80.107%
Eagle Pharmaceuticals, Inc. 406.16 Million USD 53.467%
Lantheus Holdings, Inc. 1.65 Billion USD 88.554%
Currenc Group, Inc. 141.49 Million USD -33.577%
Kamada Ltd. 351.96 Million USD 46.303%
Indivior PLC 1.95 Billion USD 90.314%
Evoke Pharma, Inc. 7.06 Million USD -2573.789%
Flora Growth Corp. 23.62 Million USD -699.958%
Cyclo Therapeutics, Inc. 13.24 Million USD -1326.665%
HUTCHMED (China) Limited 1.27 Billion USD 85.232%
Amphastar Pharmaceuticals, Inc. 1.51 Billion USD 87.508%
Akanda Corp. 8.83 Million USD -2037.988%